ImmunoPrecise Antibodies: Press Releases

ImmunoPrecise's Rapid Prime System Ensures a 65-Day Completion of Hybridoma Development Programs
Friday, June 04, 2010 by ImmunoPrecise Antibodies As a leading provider of custom monoclonal and polyclonal antibody development with over 20 years of experience, ImmunoPrecise Antibodies is well-positioned to offer some of the fastest...